WP
SLRN

Woodline Partners’s ACELYRIN SLRN Stock Holding History

Woodline Partners’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-357,094
Closed -$1.76M – 992
2024
Q3 		$1.76M Sell
357,094
-1,627,716
-82% -$8.4M 0.01% 481
2024
Q2 		$8.75M Buy
1,984,810
+963,606
+94% +$4.52M 0.08% 265
2024
Q1 		$6.89M Buy
1,021,204
+72,645
+8% +$552K 0.06% 326
2023
Q4 		$7.08M Buy
948,559
+40,646
+4% +$347K 0.08% 268
2023
Q3 		$9.23M Sell
907,913
-127,642
-12% -$2.71M 0.11% 236
2023
Q2 		$21.6M Buy
+1,035,555
New +$21.2M 0.26% 113

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Woodline Partners's SLRN Position: Q4 2024 in Review

Woodline Partners sold out of ACELYRIN (SLRN) in Q4 2024, closing a stake of 357,094 shares — an estimated $1.76M sold.

Woodline Partners first reported a position in SLRN in Q2 2023 and held it in 6 quarters. The position peaked at $21.6M in Q2 2023. 125 funds tracked by Wall St. Rank hold SLRN as of Q4 2024.

  • Woodline Partners reported no remaining ACELYRIN position as of Q4 2024 after selling out during the quarter.
  • Woodline Partners sold 357,094 ACELYRIN shares in Q4 2024, an estimated $1.76M.
  • Woodline Partners first reported a position in ACELYRIN in Q2 2023 and held it in 6 quarters.
  • Woodline Partners's ACELYRIN position peaked at $21.6M in Q2 2023.
  • 125 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2024.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.